These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30106883)

  • 21. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
    Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.
    Zhu H; Bogdanov MB; Boyle SH; Matson W; Sharma S; Matson S; Churchill E; Fiehn O; Rush JA; Krishnan RR; Pickering E; Delnomdedieu M; Kaddurah-Daouk R;
    PLoS One; 2013; 8(7):e68283. PubMed ID: 23874572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
    Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
    Glassman AH; Bigger JT; Gaffney M; Shapiro PA; Swenson JR
    Arch Gen Psychiatry; 2006 Mar; 63(3):283-8. PubMed ID: 16520433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    ; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
    JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
    Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
    J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY).
    Fava M; Dirks B; Freeman MP; Papakostas GI; Shelton RC; Thase ME; Trivedi MH; Liu K; Stankovic S
    J Clin Psychiatry; 2019 Sep; 80(6):. PubMed ID: 31556975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
    Mowla A; Kardeh E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):970-3. PubMed ID: 21291943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suicidal thinking and behavior during treatment with sertraline in late-life depression.
    Nelson JC; Delucchi K; Schneider L
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):573-80. PubMed ID: 17586782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.
    Durgam S; Chen C; Migliore R; Prakash C; Edwards J; Findling RL
    Paediatr Drugs; 2018 Aug; 20(4):353-363. PubMed ID: 29633166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
    Ball SG; Ferguson MB; Martinez JM; Pangallo BA; Nery ES; Dellva MA; Sparks J; Zhang Q; Liu P; Bangs M; Goldberger C
    J Clin Psychiatry; 2016 May; 77(5):635-42. PubMed ID: 27035159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.
    Kaddurah-Daouk R; Boyle SH; Matson W; Sharma S; Matson S; Zhu H; Bogdanov MB; Churchill E; Krishnan RR; Rush AJ; Pickering E; Delnomdedieu M
    Transl Psychiatry; 2011; 1(7):e26-. PubMed ID: 22162828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP; Søgaard J; Roponen P; Behnke K
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
    Lanza di Scalea T; Hanusa BH; Wisner KL
    J Clin Psychiatry; 2009 Mar; 70(3):423-8. PubMed ID: 19284932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.